← Leaderboards
Joshua M Thurman
University Of Colorado Denver
$14,218,696
Attributed
$20,715,691
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,715,691 · 14
By mechanism
R01$18,777,295 · 8
U01$1,111,730 · 1
K08$658,450 · 1
R03$143,906 · 1
U2C$12,714 · 1
P41$11,596 · 2
Top collaborators
- V Michael Holers6 shared
- Jessica B Kendrick6 shared
- Uwe Christians5 shared
- Raphael A. Nemenoff5 shared
- Wen-Yuan E Hsieh4 shared
- Diana I Jalal3 shared
- Richard J Smith3 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Jessica B Kendrick$6,258,606
- Lee S Newman$61,333,454
- John L. Adgate$6,465,160
- Rebecca Leanne Smathers McCullough$2,500,061
- V Michael Holers$38,234,826
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyComplementMediatingInjuryComplement ActivationPathway InteractionsKidney DiseasesNovel TherapeuticsPharmaceutical PreparationsPlasmaBaseInflammatoryTissuesCellsInflammationSiteProteinsComplement SystemExperimental StudyComplement InactivatorsIn VivoLaboratoriesAlternative Complement PathwayComplement Factor H
Grant awards (61)
The Alternative Pathway of Complement: A Potential Contributor to Adverse Outcomes in CKD$640,948
R01 · FY2025 · DK
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$543,870
R01 · FY2025 · DK
Role of the Factor H Related Proteins in Kidney Disease$481,125
R01 · FY2025 · DK · contact PI
Complement-mediated injury of the kidney: New mechanisms and novel therapies$421,214
R01 · FY2025 · DK · contact PI
Mountain States Advancement in Research, Supportive Networking and Career Development (ASCEND)$12,714
U2C · FY2025 · DK · contact PI
Spatial Mapping of Proteomic and Transcriptional Signatures in Kidney Disease$1
U01 · FY2025 · DK · contact PI
The Alternative Pathway of Complement: A Potential Contributor to Adverse Outcomes in CKD$634,659
R01 · FY2024 · DK
Role of the Factor H Related Proteins in Kidney Disease$534,582
R01 · FY2024 · DK · contact PI
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$511,651
R01 · FY2024 · DK
Complement-mediated injury of the kidney: New mechanisms and novel therapies$449,294
R01 · FY2024 · DK · contact PI
Spatial Mapping of Proteomic and Transcriptional Signatures in Kidney Disease$1
U01 · FY2024 · DK · contact PI
The Alternative Pathway of Complement: A Potential Contributor to Adverse Outcomes in CKD$629,433
R01 · FY2023 · DK
Spatial Mapping of Proteomic and Transcriptional Signatures in Kidney Disease$555,864
U01 · FY2023 · DK · contact PI
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$532,971
R01 · FY2023 · DK
Complement-mediated injury of the kidney: New mechanisms and novel therapies$468,016
R01 · FY2023 · DK · contact PI
Novel Therapeutic Approaches for Lupus Nephritis$440,908
R01 · FY2023 · DK · contact PI
Effects of Complement on the Tumor Microenvironment in Lung Cancer$394,879
R01 · FY2023 · CA
Spatial Mapping of Proteomic and Transcriptional Signatures in Kidney Disease$555,864
U01 · FY2022 · DK · contact PI
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$532,970
R01 · FY2022 · DK
Novel Therapeutic Approaches for Lupus Nephritis$440,908
R01 · FY2022 · DK · contact PI
Effects of Complement on the Tumor Microenvironment in Lung Cancer$394,879
R01 · FY2022 · CA
Evaluating the Association of Dietary Acid Load and Patterns with Cardiovascular Risk and Graft Histology in Kidney Transplant Recipients (KTRs) Across Race/Ethnicity$36,653
R01 · FY2022 · DK
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$532,560
R01 · FY2021 · DK
Novel Therapeutic Approaches for Lupus Nephritis$440,908
R01 · FY2021 · DK · contact PI
Effects of Complement on the Tumor Microenvironment in Lung Cancer$402,938
R01 · FY2021 · CA
Complement-mediated injury of the kidney: New mechanisms and novel therapies$348,305
R01 · FY2021 · DK · contact PI
Novel Therapeutic Approaches for Lupus Nephritis$440,908
R01 · FY2020 · DK · contact PI
Effects of Complement on the Tumor Microenvironment in Lung Cancer$402,938
R01 · FY2020 · CA
Immunologic Mechanisms of Progressive Glomerulosclerosis$349,875
R01 · FY2020 · DK · contact PI
Complement-mediated injury of the kidney: New mechanisms and novel therapies$348,313
R01 · FY2020 · DK · contact PI
Complement-mediated injury of the kidney: New mechanisms and novel therapies$150,835
R01 · FY2020 · DK · contact PI
Effects of Complement on the Tumor Microenvironment in Lung Cancer$416,813
R01 · FY2019 · CA
Immunologic Mechanisms of Progressive Glomerulosclerosis$349,875
R01 · FY2019 · DK · contact PI
Complement-mediated injury of the kidney: New mechanisms and novel therapies$348,322
R01 · FY2019 · DK · contact PI
Complement-mediated injury of the kidney: New mechanisms and novel therapies$360,816
R01 · FY2018 · DK · contact PI
Immunologic Mechanisms of Progressive Glomerulosclerosis$349,875
R01 · FY2018 · DK · contact PI
Immunologic Mechanisms of Progressive Glomerulosclerosis$349,875
R01 · FY2017 · DK · contact PI
Complement-mediated injury of the kidney: New mechanisms and novel therapies$338,213
R01 · FY2017 · DK · contact PI
Complement-mediated injury of the kidney: New mechanisms and novel therapies$338,213
R01 · FY2016 · DK · contact PI
In Vivo Assessment of Calcineurin Inhibitor Toxicity in Children$370,353
R01 · FY2015 · HD
Complement-mediated injury of the kidney: New mechanisms and novel therapies$338,213
R01 · FY2015 · DK · contact PI
In Vivo Assessment of Calcineurin Inhibitor Toxicity in Children$369,214
R01 · FY2014 · HD
Complement-mediated injury of the kidney: New mechanisms and novel therapies$337,125
R01 · FY2014 · DK · contact PI
In Vivo Assessment of Calcineurin Inhibitor Toxicity in Children$360,478
R01 · FY2013 · HD
Complement-mediated injury of the kidney: New mechanisms and novel therapies$336,038
R01 · FY2013 · DK · contact PI
In Vivo Assessment of Calcineurin Inhibitor Toxicity in Children$379,850
R01 · FY2012 · HD
The Complement System and Ischemic Acute Renal Failure$305,409
R01 · FY2012 · DK · contact PI
In Vivo Assessment of Calcineurin Inhibitor Toxicity in Children$379,850
R01 · FY2011 · HD
The Complement System and Ischemic Acute Renal Failure$305,409
R01 · FY2011 · DK · contact PI
COMPARE HISTOLOGIC FEATURES/MR OF KIDNEYS IN LUPUS NEPHRITIS$6,136
P41 · FY2011 · RR · contact PI
The Complement System and Ischemic Acute Renal Failure$310,789
R01 · FY2010 · DK · contact PI
COMPARE HISTOLOGIC FEATURES/MR OF KIDNEYS IN LUPUS NEPHRITIS$5,460
P41 · FY2010 · RR · contact PI
The Complement System and Ischemic Acute Renal Failure$312,545
R01 · FY2009 · DK · contact PI
The Complement System and Ischemic Acute Renal Failure$313,480
R01 · FY2008 · DK · contact PI
Complement Activation and Renal Ischemia/Reperfusion Injury$71,226
R03 · FY2008 · DK · contact PI
Complement and Ischemic Acute Renal Failure$131,490
K08 · FY2007 · DK · contact PI
Complement Activation and Renal Ischemia/Reperfusion Injury$72,680
R03 · FY2007 · DK · contact PI
Complement and Ischemic Acute Renal Failure$132,490
K08 · FY2006 · DK · contact PI
Complement and Ischemic Acute Renal Failure$131,490
K08 · FY2005 · DK
Complement and Ischemic Acute Renal Failure$131,490
K08 · FY2004 · DK
Complement and Ischemic Acute Renal Failure$131,490
K08 · FY2003 · DK